Novavax Announces Management Promotion
(Thomson Reuters ONE) -
GAITHERSBURG, Md., Oct. 01, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc.
(Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery,
development and commercialization of recombinant nanoparticle vaccines and
adjuvants, today announced that Jody Lichaa has been named Vice President,
Quality Assurance. Ms. Lichaa joined Novavax as the Executive Director, Quality
Assurance in October 2011. She is responsible for providing strategy, oversight,
and direction of the Company's quality assurance.
Prior to joining Novavax, she was Senior Director, Quality at PharmAthene from
2005 until 2011, where she managed that company's global QA/QC activities. Her
prior experience includes quality assurance positions of increasing
responsibility in a number of companies including Baxter, Shire and BioReliance.
Ms. Lichaa received her B.S. in Toxicology from Northeastern University.
"Jody has successfully developed and managed a talented quality assurance team
that has been instrumental in the ongoing development of our vaccine
candidates," said Stanley C. Erck, President and CEO. "Jody's talent and
expertise will continue to be critical as we prepare for Phase 3 development of
our RSV F Vaccines."
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to
delivering novel products to prevent a broad range of infectious diseases. Our
recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the
foundation for groundbreaking innovation that improves global health through
safe and effective vaccines. Additional information about Novavax is available
on the Company's website, novavax.com.
Contact:
Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir(at)novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull(at)russopartnersllc.com
todd.davenport(at)russopartnersllc.com
212-845-4271
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Novavax, Inc. via GlobeNewswire
[HUG#1956194]
Unternehmensinformation / Kurzprofil:
Datum: 01.10.2015 - 22:30 Uhr
Sprache: Deutsch
News-ID 424299
Anzahl Zeichen: 2883
contact information:
Town:
Maryland
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 169 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Novavax Announces Management Promotion"
steht unter der journalistisch-redaktionellen Verantwortung von
Novavax, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
